Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
21.7M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
10.7M
-
Shares change
-
-1.04M
-
Total reported value, excl. options
-
$277M
-
Value change
-
-$6.86M
-
Number of buys
-
16
-
Number of sells
-
-35
-
Price
-
$5.74
Significant Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q2 2022
58 filings reported holding XGN - EXAGEN INC. - Common Stock, par value $0.001 per share as of Q2 2022.
EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.7M shares
of 21.7M outstanding shares and own 49.44% of the company stock.
Largest 10 shareholders include HighTower Trust Services, LTA (2.68M shares), COWEN AND COMPANY, LLC (1.36M shares), Stonepine Capital Management, LLC (1.26M shares), RTW INVESTMENTS, LP (1.03M shares), WASATCH ADVISORS INC (1.01M shares), MORGAN STANLEY (499K shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (496K shares), VANGUARD GROUP INC (491K shares), PLATINUM INVESTMENT MANAGEMENT LTD (400K shares), and PERKINS CAPITAL MANAGEMENT INC (237K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.